Discover and read the best of Twitter Threads about #LBA1
Most recents (1)
@TumorBoardTues @ASCO @JohnEbbenMDPhD @SushmaJonna @HeekeMd #TumorBoardTuesday
#ASCO22 Biomarker Recap
😀Don't know about you all - but I had a great time at the meeting this year!
👉I will🔦a few biomarker based studies that caught my👁️
😉Did you notice that TWO of the plenary abstracts were for biomarker based trials‼️
#ASCO22 Biomarker Recap
😀Don't know about you all - but I had a great time at the meeting this year!
👉I will🔦a few biomarker based studies that caught my👁️
😉Did you notice that TWO of the plenary abstracts were for biomarker based trials‼️
@TumorBoardTues @ASCO @JohnEbbenMDPhD @SushmaJonna @HeekeMd @pashtoonkasi @KReissMD @DrR_DUNNE @FogacciJoao @AJacomeMD @OncBrothers @oncologician @DrSteveMartin @stolaney1 #TumorBoardTuesday
#1⃣
✅Dr. Yoshino🧑🏫the results of the Ph 3 PARADIGM trial
➡️FOLFOX-Pani vs. FOLFOX-Bev for RAS WT left CRC
👉823 Pts
👏OS>with Pani 36.2 vs. 31.3 months
👏ORR also > with Pani 75% vs. 67%
🤔BUT the curves don't separate until 26 months❓
🔎Abstract #LBA1
#1⃣
✅Dr. Yoshino🧑🏫the results of the Ph 3 PARADIGM trial
➡️FOLFOX-Pani vs. FOLFOX-Bev for RAS WT left CRC
👉823 Pts
👏OS>with Pani 36.2 vs. 31.3 months
👏ORR also > with Pani 75% vs. 67%
🤔BUT the curves don't separate until 26 months❓
🔎Abstract #LBA1
@TumorBoardTues @ASCO @JohnEbbenMDPhD @SushmaJonna @HeekeMd @pashtoonkasi @KReissMD @DrR_DUNNE @FogacciJoao @AJacomeMD @OncBrothers @oncologician @DrSteveMartin @stolaney1 #TumorBoardTuesday
#2⃣
✅Dr. Modi🧑🏫the results of the Ph 3 DESTINY-Breast04 trial
➡️T-DXd vs. SOC for HER-2 low metBreast Ca
👉557 Pts
👏PFS>with T-DXd 10.1 vs. 5.4 months
👏OS also > with T-DXd 23.9 vs. 17.5 months
🔎Abstract #LBA3
#2⃣
✅Dr. Modi🧑🏫the results of the Ph 3 DESTINY-Breast04 trial
➡️T-DXd vs. SOC for HER-2 low metBreast Ca
👉557 Pts
👏PFS>with T-DXd 10.1 vs. 5.4 months
👏OS also > with T-DXd 23.9 vs. 17.5 months
🔎Abstract #LBA3
